Withdraws Previous 2020 Growth Outlook Implementing furlough of approximately 1/3 of its direct workforce and substantially all of its temporary workforce Furloughed employees will be immediately eligible for unemployment benefits and will maintain their existing healthcare coverage through

BILLERICA, Mass. , March 02, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), announced today financial results for the fourth quarter and year ended December 31, 2019 . Q4 Summary Total revenue of $19.9 million , down 10% year-over-year on a reported basis and 9% on a constant currency

BILLERICA, Mass. , Feb. 21, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell joint replacement implants and instruments that are individually sized and shaped,

BILLERICA, Mass. , Feb. 20, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will host a webcast and conference call on Monday, March 2, 2020 , at 4:30 p.m. Eastern Time to discuss its financial results for the fourth quarter and fiscal year ended December 31 , 2019. 

Rating Highlights Positive Five-Year Survivorship Following Total Knee Arthroplasty BILLERICA, Mass. , Feb. 19, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and

Also Announces Gary Maingot as SVP, Operations; New Executive Leadership Team Members Contribute Deep Functional Expertise and Technical Knowledge; Inducement Grants Reported BILLERICA, Mass. , Feb. 05, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses

Conformis’ Patient-Specific Knee Implant Technology Is Complemented by New 3D-designed Hip System Launched in November 2019 BILLERICA, Mass. , Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis , Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology

BILLERICA, Mass. and SAN FRANCISCO , Jan. 14, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient’s unique